Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy

PURPOSE: Although neoadjuvant chemotherapy is associated with a survival advantage in pure urothelial, muscle invasive bladder cancer, the role of neoadjuvant chemotherapy is less clear in variant histology or urothelial carcinoma with divergent differentiation. We compared chemotherapy response and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Urol
Autores principales: Hajiran, Ali, Azizi, Mounsif, Aydin, Ahmet M., Zemp, Logan, Peyton, Charles C., Dhillon, Jasreman, Nealon, Samantha, Reich, Richard R., Cao, Biwei, Li, Roger, Manley, Brandon J., Sexton, Wade J., Gilbert, Scott M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864376/
https://ncbi.nlm.nih.gov/pubmed/32783489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001325
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares